Roche’s astegolimab met the main goal of one pivotal COPD study but failed another, mirroring the mixed results recently posted by a Regeneron Pharmaceuticals COPD drug candidate that goes after the same target. Biologics are a new treatment option for COPD following approvals of antibodies from Sanofi and GSK.
Climate change not only impacts patients with respiratory allergies, but it also has potential broad and emerging impacts on patients with food allergies and overall public health.
Explore top PTSD treatment centers in Arizona, offering personalized care, holistic therapies and expert support to help individuals heal and reclaim their lives.
Join us on July 21st and learn how to connect patients and caregivers in a way to extend and provide the best quality of life.
CEO Tony Keating shared some of the lessons learned from the first trial in a Skype interview from Sydney, Australia.
ResApp has developed a smartphone app that uses audio samples of a patient's cough to diagnose acute respiratory diseases. A U.S. pediatric study will assess how the app stacks up against respiratory tests conducted by hospitals to diagnose patients.
For illnesses, such as pneumonia, each person creates a unique sound signature when they cough. Based on four to five coughs, signal-processing algorithms in this app can detect those patterns, identifying both the type and severity of an ailment.
A new report by Paubox calls for healthcare IT leaders to dispose of outdated assumptions about email security and address the challenges of evolving cybersecurity threats.